MarketScreener Homepage > Equities > Deutsche Boerse AG > Canntab Therapeutics Limited TBF1 CA1377991023

Report

Delayed Deutsche Boerse AG - 01/26 02:03:04 am
0.482	EUR		-2.82%

2020

Canntab Announces Closing of Convertible Debenture Private Placement

2020

CANNTAB THERAPEUTICS : Begins Delivery of Tablets to MediPharm

2020

Canntab Therapeutics Announces End of Supply and Distribution Agreements with Exactus

Summary

Quotes 5-day view Delayed Quote.

Delayed Deutsche Boerse Ag

01/20/2021	01/21/2021	01/22/2021	01/25/2021	01/26/2021	Date
0.454(c)	0.474(c)	0.492(c)	0.496(c)	0.482(c)	Last
0	0	0	0	0	Volume
-2.58%	+4.41%	+3.80%	+0.81%	-2.82%	Change

More quotes

Financials

Sales 2019	0,24 M 0,19 M 0,19 M
Net income 2019	-2,46 M -1,94 M -1,94 M
Net cash position 2019	1,59 M 1,25 M 1,25 M
P/E ratio 2019	-7,51x
Yield 2019	-

Sales 2020	0,13 M 0,10 M 0,10 M
Net income 2020	-2,61 M -2,05 M -2,05 M
Net cash position 2020	1,36 M 1,07 M 1,07 M
P/E ratio 2020	-10,2x
Yield 2020	-

Capitalization	27,4 M 21,5 M 21,6 M
EV / Sales 2019	70,4x
EV / Sales 2020	231x
Nbr of Employees	-
Free-Float	76,0%

More Financials

Company

Canntab Therapeutics Ltd, formerly Telferscot Resources Inc, is a Canada-based company engaged in alternatywe medicine sector. The Company is dedicated to the research and development of oral dosage therapeutic formulations of cannabis and a range of oral dosage products that treat different ailments by delivering a uniform dosage of medicinal cannabis extract. The Company developed bi-layered tablets that offer an...

Sector

Pharmaceuticals

Calendar

More about the company

All news about CANNTAB THERAPEUTICS LIMITED

2020	Canntab Announces Closing of Convertible Debenture Private Placement	NE
2020	CANNTAB THERAPEUTICS : Begins Delivery of Tablets to MediPharm	PR
2020	Canntab Therapeutics Announces End of Supply and Distribution Agreements with..	NE
2020	CANN GLOBAL : Canntab to Launch in Australia and Participate in Australia's Larg..	AQ
2020	CANNTAB THERAPEUTICS : to Launch in Australia and Participate in Australia's Lar..	PR
2020	Canntab Announces Closing of Purchases of Cannabis Processing Equipment and L..	NE
2020	CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL	AQ
2020	CANNTAB THERAPEUTICS : Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tab..	AQ
2020	CANNTAB THERAPEUTICS : Granted 1st US Patent Covering Multi-Layer (Bi-Layer) Tab..	PR
2020	CANNTAB THERAPEUTICS : IIROC Trading Halt - PILL	AQ
2020	CANNTAB THERAPEUTICS : announces planned purchases of cannabis processing equipm..	AQ
2020	CANNTAB THERAPEUTICS : Appoints Larry Latowsky as CEO	AQ
2020	CANNTAB THERAPEUTICS : IIROC Trade Resumption - PILL	AQ
2020	CANNTAB THERAPEUTICS : and Medipharm Labs Enter Into a Wholesale Tablet Purchase..	AQ
2020	CANNTAB THERAPEUTICS : IIROC Trading Halt - PILL	AQ

More news

News in other languages on CANNTAB THERAPEUTICS LIMITED

2018

IRW-NEWS : Canntab Therapeutics Ltd.: Canntab announces collaboration and profit..

More news

Chart CANNTAB THERAPEUTICS LIMITED

Duration : Period :

Canntab Therapeutics Limited Technical Analysis Chart | MarketScreener

Full-screen chart

Income Statement Evolution

More Financials

Managers and Directors

Name	Title
Lawrence Latowsky	Executive Chairman & Chief Executive Officer
Jeffrey W. Renwick	President, Director & Head-Manufacturing
Richard Goldstein	Chief Financial Officer & Director
Joshi Laxminarayan	Chief Scientific Officer
Vitor Manuel Fonseca	Independent Director

More about the company

Sector and Competitors

	1st jan.	Capitalization (M$)

CANNTAB THERAPEUTICS LIMITED	-1.23%	22



CANOPY GROWTH CORPORATION	33.62%	12 566
CURALEAF HOLDINGS, INC.	24.41%	10 291
BEIJING TONGRENTANG CO., LTD	3.85%	5 253
TRULIEVE CANNABIS CORP.	37.44%	5 133
APHRIA INC.	73.98%	4 089

More Results